Sarepta Therapeutics (SRPT) PT Raised to $190 at Citi
Tweet
Share
E-mailGet Alerts SRPT Hot Sheet
Price: $18.76 +0.48%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 45
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 45
Join SI Premium – FREE
Citi analyst Joel Beatty raised the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $190.00 (from $177.00) while maintaining a Buy rating.
You May Also Be Interested In
- Vertex (VRTX) PT Raised to $615 at UBS
- Procore Technologies, Inc (PCOR) PT Lowered to $56 at DA Davidson Amid 'Less Favorable' Construction Dynamics
- Envista Holdings Corp. (NVST) PT Lowered to $26 at BMO Capital Following China VBP Commentary
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
